Evidence map›Paper›PMID 33185010›Full record

ArticleFEBS open bio2021

Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer's disease rats.

Myrthe Mampay, María Velasco-Estevez, Sara O Rolle, Aisling M Chaney, Hervé Boutin, Kumlesh K Dev, Emad Moeendarbary, Graham K Sheridan

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. REST in the Road Map of Brain Development.Cellular and molecular neurobiology · 2023
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Myrthe MampaySchool of Pharmacy and Biomolecular Sciences, University of Brighton, UK.
María Velasco-EstevezDrug Development, Department of Physiology, School of Medicine, Trinity College Dublin, Ireland.ORCID 0000-0002-2886-122X
Sara O RolleThe Sainsbury Welcome Centre for Neural Circuits and Behaviour, University College London, UK.
Aisling M ChaneyFaculty of Biology, Medicine and Health, School of Health Sciences, Division of Informatics, Imaging and Data Sciences, University of Manchester, UK.
Hervé BoutinWolfson Molecular Imaging Centre, University of Manchester, UK.
Kumlesh K DevDrug Development, Department of Physiology, School of Medicine, Trinity College Dublin, Ireland.
Emad MoeendarbaryDepartment of Mechanical Engineering, University College London, UK.
Graham K SheridanSchool of Life Sciences, Queens Medical Centre, University of Nottingham, UK.ORCID 0000-0002-8493-2651
Manchester Academic Health Science Centre · GBTrinity College Dublin · IESainsbury Laboratory · GBUniversity College London · GBUniversity of Brighton · GBUniversity of Nottingham · GB

Funding

Cancer Research UK C416/A25145Cancer Research UK C57744/A22057
6 · The paper itself

Abstract

In the brain, REST (Repressor Element-1 Silencing Transcription factor) is a key regulator of neuron cell-specific gene expression. Nuclear translocation of neuronal REST has been shown to be neuroprotective in a healthy ageing context. In contrast, inability to upregulate nuclear REST is thought to leave ageing neurons vulnerable to neurodegenerative stimuli, such as Alzheimer's disease (AD) pathology. Hippocampal and cortical neurons are known to be particularly susceptible to AD-associated neurodegeneration. However, REST expression has not been extensively characterised in the healthy ageing brain. Here, we examined the spatiotemporal immunolocalisation of REST in the brains of healthy ageing wild-type Fischer-344 and transgenic Alzheimer's disease rats (TgF344-AD). Nuclear expression of REST increased from 6 months to 18 months of age in the hippocampus, frontal cortex and subiculum of wild-type rats, but not in TgF344-AD rats. No changes in REST were measured in more posterior cortical regions or in the thalamus. Interestingly, levels of the presynaptic marker synaptophysin, a known gene target of REST, were lower in CA1 hippocampal neurons of 18-month TgF344-AD rats compared to 18-month wild-types, suggesting that elevated nuclear REST may protect against synapse loss in the CA1 of 18-month wild-type rats. High REST expression in ageing wild-type rats did not, however, protect against axonal loss nor against astroglial reactivity in the hippocampus. Taken together, our data confirm that changes in nuclear REST expression are context-, age- and brain region-specific. Moreover, key brain structures involved in learning and memory display elevated REST expression in healthy ageing wild-type rats but not TgF344-AD rats.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsCA1 Region, HippocampalDisease Models, AnimalFemaleFrontal LobeHealthy AgingHumansLearningMaleMemoryMutationNeuronsPresenilin-1RatsAmyloid beta-Protein PrecursorAPP protein, humanPresenilin-1PSEN1 protein, humanRE1-Silencing Transcription FactorRepressor ProteinsSynaptophysinageingAlzheimer’s diseasehippocampusRESTsynapseTgF344-AD rats

Identifiers

PMID33185010
PMCPMC7780110
OpenAlexW3104592017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.